TABLE 3.
Number (percentage) of cases that met constraints for each model.
| Structure | Constraint | Clinical | Dose/Volume | gEUD | Lines |
|---|---|---|---|---|---|
| PTV | D0.03cc < 110% | 13 (52%) | 23 (92%) | 4 (16%) | 23 (92%) |
| D0.03cc < 115% | 25 (100%) | 25 (100%) | 19 (76%) | 25 (100%) | |
| Esophagus | D0.03cc < 105% | 24 (96%) | 15 (60%) | 9 (36%) | 15 (60%) |
| DMean < 34 Gy | 25 (100%) | 25 (100%) | 25 (100%) | 25 (100%) | |
| Heart | DMean < 20 Gy | 25 (100%) | 23 (92%) | 23 (92%) | 23 (92%) |
| DMean < 26 Gy | 25 (100%) | 25 (100%) | 25 (100%) | 25 (100%) | |
| Lungs | V20Gy < 33% | 20 (80%) | 20 (80%) | 21 (84%) | 21 (84%) |
| V20Gy < 37% | 25 (100%) | 22 (88%) | 22 (88%) | 22 (88%) | |
| V5Gy < 65% | 15 (60%) | 15 (60%) | 16 (64%) | 15 (60%) | |
| Spinal cord | D0.03cc < 45 Gy | 25 (100%) | 25 (100%) | 25 (100%) | 25 (100%) |
| D0.03cc < 50 Gy | 25 (100%) | 25 (100%) | 25 (100%) | 25 (100%) |
Note: Constraints come from our institutional clinical protocols which were developed based on consensus among disease site‐specific physician groups. Hard constraints are bolded.